The Early Access program is currently available in New Zealand, United Kingdom, Switzerland, Germany and Ireland (While the USA (FDA) approves treatments, the process is too costly and time consuming so American patients choose to fly abroad instead. While Australia approves treatments the administration has turned out to be costly so patients choose to fly to New Zealand instead.
The scientific literature has firmly established that mercury causes a biochemical train wreck especially in the brain where it is linked to a host of neurological illnesses and oxidative stress.
Learn about our company, mission and board of directors.
Irminix® has been approved for compassionate use.
Latest News, Research, Clinical Trials, Press and Newsletters.
Investor Information about EmeraMed Ltd.
Discover The Future of Health
We are committed to improving health by way of our unique metal chelator and antioxidant, Irminix®